The INCLIVA Health Research Institute, affiliated with the University Clinical Hospital of Valencia, has received a 10,000 euro donation from the Teulada Moraira Association Against Cancer. These funds will be allocated to advancing pancreatic cancer research.
The handover ceremony took place at INCLIVA's facilities, attended by association representatives such as Sandra Navalmoral, Bernardo Martí, Carlos Linares, and Vicen Cantó. INCLIVA was represented by its scientific director, Dr. Andrés Cervantes; managing director, Vicente de Juan; Dr. Marisol Huerta, from the Research Group in colorectal cancer and new therapeutic developments in solid tumors; and general secretary, Maite Sáenz.
This marks the third collaboration between the association and INCLIVA. Previously, in 2023, the entity contributed 5,000 euros for triple-negative breast cancer research, followed by a second donation in 2024 for a liquid biopsy project, a line to which part of this new donation will also be directed.
Dr. Andrés Cervantes highlighted the social support for INCLIVA's research, noting that donations are crucial for initiating new projects. He also emphasized that these actions help to raise awareness and bring research closer to society, fostering social consciousness.
Dr. Marisol Huerta stressed the importance of publicizing tumors like pancreatic cancer, which is the third leading cause of cancer death in Spain despite ranking seventh in incidence. She explained that non-specific symptoms hinder early diagnosis, and the lack of effective treatments increases mortality. She insisted on the need to promote research across all its phases.
Representatives from the Teulada Moraira Association Against Cancer agreed on the necessity for further study of this tumor, which is often diagnosed when the disease has already spread. They expressed their hope that research will lead to markers for earlier detection and more effective treatments.
The entity recognized INCLIVA's research teams as "special professionals" for improving society's quality of life. They expressed pride that such research is conducted in their region and emphasized that every euro raised is fully dedicated to research, always striving to translate contributions into tangible resources for donors.
INCLIVA's managing director, Vicente de Juan, thanked the association for its generosity, explaining that such collaborations are vital for advancing projects when competitive funding is not immediately available.
Dr. Andrés Cervantes concluded by recalling that institutes like INCLIVA serve as a bridge between basic research and society, a link that collaborations like the one with the Teulada Moraira Association Against Cancer help to strengthen.
